eli lilly sues four telehealth compounding glp-1 companies FDA issued 25 warning letters to for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The drug company Eli Lilly

the program demonstrated a favorable safety profile but the Phase IIb obesity trial produced modest weight-loss effects (mean reduction in treated groups roughly 2.6 kg vs

GLP-1 agonists reduce insulin levels, and lower insulin triggers the kidneys to release stored sodium and water

Studies show it lowers chromosomal aberrations by over 17%

Impact of coronary lesion progression on MACEs in T2D patients Coronary lesion progression, including in-stent restenosis (ISR) and non-target lesion progression (NTLP), significantly impacts major adverse cardiovascular events (MACEs) in type 2 diabetes (T2D) patients post-PCI

A functional wellness drink with sweetener, containing L-carnitine and vitamins

Anjana RM, Pradeepa R, Unnikrishnan R, Tiwaskar M, Aravind SR, Saboo B, Joshi SR, Mohan V